1. Disseminated Mycobacterium haemophilum infection.
- Author
-
Kelley CF, Armstrong WS, and Eaton ME
- Subjects
- Acquired Immunodeficiency Syndrome drug therapy, Acquired Immunodeficiency Syndrome immunology, Cellulitis drug therapy, Cellulitis immunology, Clarithromycin administration & dosage, Humans, Immunocompromised Host, Male, Middle Aged, Mycobacterium Infections drug therapy, Mycobacterium Infections immunology, Ofloxacin administration & dosage, Rifabutin administration & dosage, Acquired Immunodeficiency Syndrome virology, Anti-Bacterial Agents administration & dosage, Anti-HIV Agents administration & dosage, Cellulitis microbiology, HIV immunology, Mycobacterium Infections virology, Mycobacterium haemophilum immunology
- Abstract
Mycobacterium haemophilum is a slow-growing organism first identified in 1978. Since that time, it has emerged as an unusual pathogen, but one that is identified increasingly, mainly affecting immunocompromised patients and healthy children. The range of disease caused by this organism includes skin and soft-tissue infections, pulmonary infections, lymphadenitis, and frequently, bone and joint infections. Laboratory identification of M haemophilum needs special culture techniques and media and can be difficult in a setting at which these methods are not routinely used. We describe a case of chronic, disseminated M haemophilum infection in a patient with AIDS, and we review published work., (Copyright © 2011 Elsevier Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF